SPECIFIC USE OF SCREENING IMMUNOCHROMATOGRAPHIC TESTS FOR THE PRIMARY DETECTION OF FACTS OF PSYCHOACTIVE SUBSTANCE USE IN URINE AND SALIVA
The use of narcotic substances is a serious social problem, a threat to the health of an individual and to the security of the country as a whole. The use of narcotic substances affects the safety of the overall productivity of labor, which, ultimately, creates a rather large burden on the economy of the country as a whole. In the framework of federal programs for the prevention of drug addiction, the practice of testing for the use of narcotic drugs at work and study places is being increasingly used. And here the question naturally arises of the signiﬁcant cost, laboriousness and time-consuming test systems for the use of narcotic substances produced by Russian companies. All this, of course, complicates the process of introducing a testing procedure. In this situation, the importance of developing, improving and introducing new methods for the detection of narcotic substances and their metabolites in human biological ﬂuids increases. The article provides a general overview of world experience in using immunochromatographic tests for identifying psychoactive substances as a screening test, with particular attention being paid to analyzing the speciﬁcs of using screening immunochromatographic tests for the initial identiﬁcation of psychoactive substances in urine and saliva from the standpoint of the contextual feasibility of their applicability in a number of speciﬁc cases related to the speciﬁcs of the professional activities of the test. Along with this, the author, on the basis of the available statistical information and original research materials, provides an analysis of the Russian market of test systems for the detection of psychoactive substances in saliva and examines the feasibility of expanding its capabilities through wider use of screening psychoactive substances for saliva.